Clinique partners with Icahn School of Medicine to launch skin health center

Clinique, a leading skincare brand, and the Icahn School of Medicine at Mount Sinai have announced a groundbreaking philanthropic partnership to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center. This collaboration marks a significant advancement in dermatology research, focusing on the biological mechanisms of skin aging, skin allergies, and inflammatory conditions such as eczema (atopic dermatitis) and contact dermatitis. Rooted in a shared commitment to improving patient care through scientific discovery, this partnership aims to propel allergy science forward and develop innovative solutions for prevalent skin conditions.

The Mount Sinai-Clinique Healthy Skin Dermatology Center will spearhead research into the underpinnings of skin conditions, aiming to bridge the gap between basic science and clinical application. By exploring healthy skin alongside skin affected by allergic disorders, the center seeks to unveil strategies to significantly slow down the visible signs of aging and improve the quality of life for individuals with eczema and other skin allergies. The insights gained are expected to drive progress in dermatology and inspire Clinique’s future product development, particularly for those with allergic or sensitive skin.

Clinique and Icahn School of Medicine at Mount Sinai

Michelle Freyre, President of Global Brands at Clinique, expressed enthusiasm for the collaboration, highlighting the brand’s long-standing commitment to dermatologist-guided, allergy-tested solutions. The partnership with Icahn Mount Sinai and its team of physician-scientists, led by Dr. Emma Guttman, a world-renowned expert in allergic and inflammatory skin diseases, is anticipated to yield groundbreaking research that will advance allergy science.

Dr. Emma Guttman’s work has already led to significant therapeutic discoveries for inflammatory skin conditions, driven by her personal commitment to alleviating sensitive skin. The partnership aims to explore targeted approaches to reversing allergic skin conditions and addressing age-related inflammation, known as “inflammaging,” to promote sustained healthy skin.

The Laboratory of Inflammatory Skin Diseases at Icahn Mount Sinai, under Dr. Guttman’s leadership, has been pivotal in identifying the immunologic basis of atopic dermatitis and developing comprehensive molecular maps of the condition. This work has directly contributed to the development of recent treatments for atopic dermatitis, cementing Dr. Guttman’s status as a leader in dermatology and immunology.

The partnership between Clinique and the Icahn School of Medicine at Mount Sinai represents a significant leap in dermatology research, with the potential to transform care for patients with skin allergies and aging concerns. By combining Clinique’s innovation in skincare with Mount Sinai’s research excellence, this alliance is poised to make substantial contributions to the understanding and treatment of skin conditions, potentially leading to breakthroughs in therapeutic approaches and skincare products.